DeutschNewstral
Article
Bbarrons.com on 2022-11-03 09:35
Weight-Loss Drug Shortage Fixed by Year End: Novo Nordisk3 min read
Related news
- BWeight-Loss Drug Shortage Fixed by Year End: Novo Nordisk3 min readbarrons.com
- MNovo Nordisk lifts guidance as earnings beat expectations1 min readmarketwatch.com
- BDicerna Stock Skyrockets as Novo Nordisk to Buy Research Partner for $3.3 Billion1 min readbarrons.com
- BNew Obesity Drugs From Lilly and Novo Nordisk Generate Excitement3 min readbarrons.com
- BLilly and Novo Stock Sold Off. Don't Blame Their Diet Drugs.3 min readbarrons.com
- B4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.2 min readbarrons.com
- MNovo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts1 min readmarketwatch.com
- BWeight-Loss Drugs That Work and a Black Pioneer: Community Conversations5 min readbarrons.com
- MLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'4 min readmarketwatch.com
- BRoche Strikes $3.1 Billion Deal for Obesity Drugmaker. It Hopes to Compete with Eli Lilly, Novo Nordisk. 2 min readbarrons.com
- MAs Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion2 min readmarketwatch.com
- BWeek's Best: Rethinking Fixed Income3 min readbarrons.com
- MRoche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic2 min readmarketwatch.com
Sales skyrocket for weight-loss drug firm Novo Nordiskeuronews
Novo Nordisk’s weight-loss drug cuts heart failure symptomsPolitico.eu
Novo Nordisk Beats Profit Forecasts As Weight-Loss Sales SoarForbes
Novo weight-loss drug Wegovy shows heart benefit in trialNew York Post- Novo Nordisk’s weight loss drug launches in UKPolitico.eu
- MRetirees don't live on 'fixed incomes'3 min readmarketwatch.com
Novo Nordisk AS: Novo Nordisk’s sales of weight loss drugs soarFinancial Times